Alessandro Cuneo

Stadtlohn, NW, DE 
Stadtlohn, NW, DE 

Overview

Alessandro Cuneo practices practicing medicine in Stadtlohn, Germany.

His clinical expertise encompasses Cardiogenic Shock, Fainting, Heart Attack, Atrial Fibrillation, and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Stadtlohn, NW, Germany
Other Locations
St. Marien Hospital, Ahaus, NW, Germany
Stadtlohne, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Enrollment Status: Completed
Publish Date: June 29, 2025
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
Enrollment Status: Unknown
Publish Date: April 20, 2023
Intervention Type: Device
BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
Enrollment Status: Unknown
Publish Date: April 20, 2023
Intervention Type: Device
View 2 Less Clinical Trials

35 Total Publications

OPTimizing Beta-Blocker Dosage in Women Using the Wearable Cardioverter-Defibrillator (OPT-BB Women): Study design.
OPTimizing Beta-Blocker Dosage in Women Using the Wearable Cardioverter-Defibrillator (OPT-BB Women): Study design.
Journal: Heart rhythm O2
Published: March 30, 2026

Frequently Asked Questions about Alessandro Cuneo

Is Alessandro Cuneo a top-rated expert for Cardiogenic Shock?

MediFind is an objective health platform that identifies experts based on real-world data. Alessandro Cuneo is classified as an Experienced expert for Cardiogenic Shock, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alessandro Cuneo participate in research or clinical trials?

Yes. Alessandro Cuneo has published 35 articles and abstracts on conditions like Cardiogenic Shock. You can view a list of Alessandro Cuneo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cuneo's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile